Kestra Medical Technologies Growth Metrics (2024-2025) | KMTS

Growth Metrics Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025
Growth Ratios
Assets Growth (1y) 543.64%
Assets (QoQ) 173.85%-9.96%-7.36%
Capital Expenditures Growth (1y) 79.82%16.04%63.37%
Capital Expenditures (QoQ) 71.26%-36.81%-8.64%81.86%10.52%-11.03%
Cash & Equivalents Growth (1y) 254.20%2,780.29%101.28%128.07%
Cash & Equivalents (QoQ) -46.24%1,111.89%-23.06%-29.34%337.14%-15.31%-12.82%
Cash from Investing Activities Growth (1y) -86.61%-17.03%-67.87%
Cash from Investing Activities (QoQ) -69.13%37.16%7.40%-89.62%-6.07%9.86%
Cash from Operations Growth (1y) -58.54%-50.15%-1.59%
Cash from Operations (QoQ) -17.07%-3.18%-1.65%-29.12%-10.87%30.19%
EBITDA Margin Growth (1y) 10,446.00-7737.00-488.00-1065.00
EBITDA Margin (QoQ) 3,858.005,820.001,412.00-645.00-14324.0013,069.00835.00
EBIT Growth (1y) -3.28%-136.93%-56.68%-65.96%
EBIT Margin Growth (1y) 10,446.00-7737.00-488.00-1065.00
EBIT Margin (QoQ) 3,858.005,820.001,412.00-645.00-14324.0013,069.00835.00
EBIT (QoQ) -2.02%9.43%-3.81%-7.67%-134.03%40.10%-9.96%
EBT Growth (1y) -0.63%-128.63%-26.96%-58.89%
EBT Margin Growth (1y) 11,695.00-7408.002,579.00-501.00
EBT Margin (QoQ) 3,911.006,297.001,881.00-395.00-15192.0016,284.00-1199.00
EBT (QoQ) -3.27%8.94%-1.46%-5.47%-134.62%49.43%-26.98%
Enterprise Value Growth (1y) -148.90%12,196.66%746.24%1,703.33%
Enterprise Value (QoQ) 46.24%-1,111.89%23.06%50.34%2,712.59%-35.26%90.89%
EPS (Basic) Growth (1y) -5.93%-28.69%55.36%46.22%
EPS (Basic) (QoQ) -3.39%8.20%-6.25%-5.04%-25.60%68.15%-28.00%
EPS (Weighted Average and Diluted) Growth (1y) -5.93%-28.69%55.36%46.22%
EPS (Weighted Average and Diluted) (QoQ) -3.39%8.20%-6.25%-5.04%-25.60%68.15%-28.00%
FCF Margin Growth (1y) 915.001,417.003,949.00
FCF Margin (QoQ) -241.003,898.00442.00-3184.00261.006,431.00
Free Cash Flow Growth (1y) -63.13%-40.37%-13.80%
Free Cash Flow (QoQ) -28.75%8.29%0.38%-38.68%-10.78%25.64%
Gross Margin Growth (1y) 3,275.003,040.001,283.001,099.00
Gross Margin (QoQ) 326.001,896.00677.00375.0091.00140.00494.00
Gross Profit Growth (1y) 643.98%446.39%110.74%95.95%
Gross Profit (QoQ) 58.75%200.64%38.81%12.30%16.59%15.96%29.07%
Interest Coverage Ratio Growth (1y) 4.36%-160.48%-53.57%-102.28%
Interest Coverage Ratio (QoQ) 12.95%6.48%16.03%-39.91%-137.09%44.86%-10.60%
Net Cash Flow Growth (1y) 2,766.90%-139.67%-11.88%
Net Cash Flow (QoQ) 1,434.89%-125.13%2.10%912.03%-119.85%29.11%
Net Income Growth (1y) -0.65%-129.36%-27.08%-58.99%
Net Income (QoQ) -3.08%8.80%-1.47%-5.52%-134.90%49.47%-26.95%
Net Income towards Common Stockholders Growth (1y) -5.98%-127.96%-15.98%-38.39%
Net Income towards Common Stockholders (QoQ) -3.61%8.28%-6.40%-4.82%-122.86%53.34%-26.95%
Net Margin Growth (1y) 11,852.00-7968.004,088.001,576.00
Net Margin (QoQ) 4,161.006,727.001,315.00-351.00-15659.0018,783.00-1197.00
Operating Income Growth (1y) -3.28%-136.93%-56.68%-65.96%
Operating Income (QoQ) -2.02%9.43%-3.81%-7.67%-134.03%40.10%-9.96%
Operating Margin Growth (1y) 10,446.00-7737.00-488.00-1065.00
Operating Margin (QoQ) 3,858.005,820.001,412.00-645.00-14324.0013,069.00835.00
Profit After Tax Growth (1y) -0.65%-129.36%-27.08%-58.99%
Profit After Tax (QoQ) -3.08%8.80%-1.47%-5.52%-134.90%49.47%-26.95%
Property, Plant & Equipment (Net) Growth (1y) 33.42%
Property, Plant & Equipment (Net) (QoQ) 10.97%15.92%13.76%
Return on Assets (QoQ) 14.00-9.00
Return on Capital Employed (QoQ) 18.00-12.00
Return on Equity Growth (1y) -113.00
Return on Equity (QoQ) -13.0063.00-148.00-14.00
Return on Sales Growth (1y) 8.00
Return on Sales (QoQ) 24.00-29.0011.003.00
Revenue Growth (1y) 82.31%71.40%51.55%53.40%
Revenue (QoQ) 21.47%27.13%15.08%2.58%14.20%12.41%16.49%
Share-based Compensation Growth (1y) 23.39%5,635.99%1,114.59%671.21%
Share-based Compensation (QoQ) 4.57%-3.08%197.61%-59.09%4,761.22%-79.48%88.97%
Shareholder's Equity Growth (1y) -21.88%198.10%185.07%169.37%
Shareholder's Equity (QoQ) 45.50%-3.39%-9.27%-97.93%143.87%-10.34%-10.90%
Total Debt Growth (1y) -3.38%
Total Debt (QoQ) -6.06%0.94%0.93%